MediWound Analyst Price Targets - Benzinga

MediWound Ltd

MDWDNASDAQ

Trade with Public

Trade with Public

$12.60

0.605%

마지막 업데이트: Oct 20, 9:30 AM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

MediWound Analyst Price Targets

Wall Street analyst price targets and consensus rating for MediWound (MDWD).

Price Target Range — 10 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$34Upside to Avg. PT+171.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Oppenheimer	Jeff Jones	PT Cut	Outperform	$32→$30
May 28, 2026	Oppenheimer	Francois Brisebois	PT Cut	Outperform	$33→$32
May 28, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$36
Nov 21, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$31→$36
May 22, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$25→$31
Mar 20, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$25
Feb 28, 2025	Craig-Hallum	Chase Knickerbocker	Initiate	Buy	$39
Jan 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$25
Nov 27, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$28→$25
Oct 11, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$28
Aug 15, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$28
Jul 16, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$28
May 30, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$28
Mar 22, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$28
Jan 16, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$26→$28
Nov 22, 2023	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$26

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30

Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $32 to $30.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

Oppenheimer analyst Francois Brisebois maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $33 to $32.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $36 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $36 price target.

Benzinga Newsdesk

Palo Alto To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $36

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MediWound (NASDAQ:MDWD) with a Buy and raises the price target from $31 to $36.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on MediWound, Raises Price Target to $31

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MediWound (NASDAQ:MDWD) with a Buy and raises the price target from $25 to $31.

Benzinga Newsdesk